Hemoglobin Meter Market Report 2026

Hemoglobin Meter Market Overview

• Hemoglobin Meter market size has reached to $2.75 billion in 2025 • Expected to grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Anemia Surge Boosts Hemoglobin Meter Market • Market Trend: Advancements In Hemoglobin Measurement For Anemia Patients • North America was the largest region in 2025.

What Is Covered Under Hemoglobin Meter Market?

A hemoglobin meter refers to a device used to measure the concentration of hemoglobin in the blood. It's commonly used for monitoring anemia, assessing overall blood health, and guiding treatment decisions. Some meters are designed for home use, allowing individuals to check their hemoglobin levels regularly. The main types of hemoglobin meters are full-automatic and semi-automatic. Full automatic hemoglobin meters perform all the necessary steps in measuring hemoglobin levels automatically, reducing the potential for human error and ensuring consistent results. The product types include bench tops and portables for applications such as hospitals, labs, and others.

What Is The Hemoglobin Meter Market Growth Forecast?

The hemoglobin meter market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growth in home healthcare diagnostics, rising adoption of portable and handheld devices, increasing screening programs for anemia, technological improvements in sensor accuracy, expansion of point-of-care testing in rural and remote areas. Major trends in the forecast period include rising adoption of portable and home-use hemoglobin meters, increasing demand for rapid point-of-care testing, growing focus on early anemia detection and monitoring, expansion of hemoglobin testing in primary healthcare settings, improved accuracy and ease of use in handheld devices.

What Is The Driver Of The Hemoglobin Meter Market?

The rising prevalence of anemia is expected to propel the growth of the hemoglobin meter market going forward. Anemia is a condition characterized by a deficiency of red blood cells, or hemoglobin, leading to reduced oxygen transport in the body. The rising prevalence of anemia is driven by nutrient deficiencies, particularly in iron, vitamin B12, and folate, often due to poor dietary habits and limited access to nutrient-rich foods. Additionally, poverty, lack of access to healthcare, and genetic disorders can cause chronic anemia by disrupting red blood cell production. A hemoglobin meter is used in anemia to measure the concentration of hemoglobin in the blood, helping to diagnose and monitor the severity of the condition. For instance, in July 2023, according to the Institute for Health Metrics and Evaluation (IHME), a U.K.-based national and international public health agency and research institute, nearly 2 billion people worldwide were affected by anemia, with a higher prevalence in women compared to men. Globally, 31.2% of women had anemia, compared to 17.5% for men. This gender disparity was particularly evident during the reproductive years (ages 15–49), with anemia affecting 33.7% of women compared to 11.3% of men in this age group. Therefore, the rising prevalence of anemia will drive the growth of the hemoglobin meter industry.

Key Players In The Global Hemoglobin Meter Market

Major companies operating in the hemoglobin meter market are F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Beckman Coulter Inc, Sysmex Corporation, Nihon Kohden Corporation, Nova Biomedical Corporation, Instrumentation Laboratory Company, ACON Laboratories Inc, Erba Diagnostics Mannheim GmbH, Transasia Bio-Medicals Ltd, Trinity Biotech, HemoCue AB, EKF Diagnostics Holdings plc, Boule Diagnostics AB, PTS Diagnostics, HUMAN Diagnostics Worldwide, PixCell Medical Technologies Ltd

Global Hemoglobin Meter Market Trends and Insights

Major companies operating in the hemoglobin meter market are focusing on innovative solutions such as fingerstick blood tests to reduce healthcare costs associated with laboratory visits. The fingerstick blood test is a quick and minimally invasive technique for collecting blood samples via a small skin puncture, enabling rapid and convenient health monitoring from home. For instance, in October 2023, Sanguina Inc., a US-based medical biotechnology company, received clearance from the U.S. Food and Drug Administration (FDA) for its home hemoglobin test kit, AnemoCheck Home. Which is a home hemoglobin test kit that enables individuals to conveniently monitor their hemoglobin levels from the comfort of their own homes. As the sole FDA-approved home hemoglobin test in the United States, it caters to those with conditions such as anemia resulting from nutritional deficiencies, thalassemia, and sickle cell disease. The kit employs an easy fingerstick blood collection technique, allowing users to obtain a blood sample with minimal discomfort.

What Are Latest Mergers And Acquisitions In The Hemoglobin Meter Market?

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based medical technology provider, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. The acquisition aims to boost Mindray's global position in the IVD sector by utilizing DiaSys's established supply chains and clinical chemistry expertise. This move is expected to enhance Mindray's offerings for medium- to large-volume customers and improve service delivery. DiaSys Diagnostic Systems GmbH is a Germany-based diagnostic system manufacturer offering hemoglobin meters for blood tests.

What Defines the Hemoglobin Meter Market?

The hemoglobin meter market consists of sales of handheld hemoglobin meters, wireless hemoglobin meters, integrated diagnostic systems, automated analyzers, and multi-parameter testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hemoglobin Meter Market Report 2026?

The hemoglobin meter market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin meter industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.